This inventor holds 4 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Kao Corporation. Active years: 2015-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Wakayama, JP (2015)
- Omiya-ku, JP (2021)
- Saitama, JP (2022)
Company Filing History:
Years Active: 2015-2022
Title: Masazumi Iwashita: Innovator in Bioabsorbable Formulations
Introduction
Masazumi Iwashita is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of bioabsorbable formulations, holding a total of 4 patents. His work focuses on enhancing the bioavailability of various compounds, which is crucial for effective oral medications.
Latest Patents
Iwashita's latest patents include a highly absorbable oral tyrosine formulation. This innovative formulation is designed to improve the bioabsorbability of tyrosine when ingested orally. It includes glycyltyrosine or a salt thereof, or a solvate thereof, ensuring that the body can effectively utilize this important amino acid. Another significant patent is for a method of producing a solid dispersion containing nobiletin. This method provides a nobiletin composition with excellent solubility in water, simplifying the production process and enhancing the compound's usability in various applications.
Career Highlights
Masazumi Iwashita is currently employed at Kao Corporation, where he continues to develop innovative solutions in the field of bioabsorbable formulations. His expertise and dedication to research have positioned him as a key figure in his industry.
Collaborations
Iwashita collaborates with talented coworkers, including Kotaro Tamura and Yoshihiko Minegishi. Their combined efforts contribute to the advancement of innovative formulations and methods within their field.
Conclusion
Masazumi Iwashita's work in developing bioabsorbable formulations has made a significant impact on the pharmaceutical industry. His innovative patents and collaborations highlight his commitment to enhancing the effectiveness of oral medications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
